Peru DIGEMID registration DMDIV5659E
ATELLICA CH DIAZO DIRECT BILIRUBIN (D_DBIL); ATELLICA CH DIAZO TOTAL BILIRUBIN (D_TBIL).
Device classification
- Product Type
- IN VITRO MEDICAL DEVICE
Registration information
- Analysis ID
- DMDIV5659E
- Registration Date
- July 24, 2024
- Expiration Date
- July 24, 2029
- Creation Date
- February 17, 2025
Manufacturer
Authorized Representative
About this record
Access comprehensive regulatory information for ATELLICA CH DIAZO DIRECT BILIRUBIN (D_DBIL); ATELLICA CH DIAZO TOTAL BILIRUBIN (D_TBIL). in the Peru medical device market through Pure Global AI's free database. This medical device is registered under DIGEMID ID DMDIV5659E and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC. The device was registered on July 24, 2024.
This page provides complete registration details including product type (IN VITRO MEDICAL DEVICE), manufacturer information, authorized representative details, and regulatory compliance data from the official Peru DIGEMID medical device database. Pure Global AI offers free access to Peru's complete medical device registry.
Free DatabasePowered by Pure Global AIDIGEMID Official Data